NDAORALCAPSULEPriority Review
Approved
Nov 1957
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 19h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DARVON COMPOUND is a fixed-dose oral analgesic combining propoxyphene hydrochloride (an opioid), aspirin, and caffeine in capsule form. Approved in 1957, it was indicated for mild-to-moderate pain relief, leveraging propoxyphene's analgesic properties combined with aspirin's anti-inflammatory action and caffeine's adjuvant effect. The product represents a legacy combination therapy approach to pain management.
LOE Approaching
With LOE approaching and minimal current linked job activity, this product faces declining commercial momentum and likely reduced team investment.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
With zero linked job openings and LOE approaching, DARVON COMPOUND offers minimal career growth opportunity. This assignment signals a mature or declining portfolio role, best suited for professionals managing legacy products or transitioning portfolios rather than those seeking growth-stage brand experience.
Brand ManagerSales Representative
Worked on DARVON COMPOUND at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.